<bill session="106" type="h" number="4743" updated="2013-07-14T18:54:56-04:00">
  <state datetime="2000-06-26">REFERRED</state>
  <status>
    <introduced datetime="2000-06-26"/>
  </status>
  <introduced datetime="2000-06-26"/>
  <titles>
    <title as="introduced" type="short">Drug Availability and Health Care Access Improvement Act of 2000</title>
    <title as="introduced" type="official">To amend the Social Security Act to improve access to prescription drugs for low-income Medicare beneficiaries, the Internal Revenue Code and other Acts to improve access to health care coverage for seniors, the self-employed, and children, and to amend the Federal Food, Drug, and Cosmetic Act to improve meaningful access to reasonably priced prescription drugs.</title>
  </titles>
  <sponsor id="400517"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2000-06-26">
      <text>Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2000-06-26">
      <text>Referred to House Commerce</text>
    </action>
    <action datetime="2000-06-26">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2000-07-14">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Advertising"/>
    <term name="Aliens"/>
    <term name="Antitrust law"/>
    <term name="Business income tax"/>
    <term name="Capitation (Medical care)"/>
    <term name="Child health"/>
    <term name="Commerce"/>
    <term name="Competition"/>
    <term name="Consumer education"/>
    <term name="Corporate mergers"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and public finance"/>
    <term name="Electronic data interchange"/>
    <term name="Families"/>
    <term name="Federal aid to child health services"/>
    <term name="Federal aid to maternal health services"/>
    <term name="Finance and financial sector"/>
    <term name="Foreign trade and international finance"/>
    <term name="Gifts"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Health insurance"/>
    <term name="Health maintenance organizations"/>
    <term name="Immigrant health"/>
    <term name="Immigration"/>
    <term name="Imports"/>
    <term name="Income tax"/>
    <term name="Insurance premiums"/>
    <term name="Intergovernmental fiscal relations"/>
    <term name="Managed care"/>
    <term name="Maternal health services"/>
    <term name="Medicaid"/>
    <term name="Medical economics"/>
    <term name="Medically uninsured"/>
    <term name="Medicare"/>
    <term name="Medicare managed care"/>
    <term name="Pediatricians"/>
    <term name="Personal income tax"/>
    <term name="Poor"/>
    <term name="Poor children"/>
    <term name="Poor women"/>
    <term name="Pregnant women"/>
    <term name="Prescription pricing"/>
    <term name="Price fixing"/>
    <term name="Science, technology, communications"/>
    <term name="Self-employed"/>
    <term name="Social welfare"/>
    <term name="State laws"/>
    <term name="Tax deductions"/>
    <term name="Taxation"/>
    <term name="Telephone"/>
    <term name="Vaccination"/>
    <term name="Welfare eligibility"/>
    <term name="Women"/>
  </subjects>
  <amendments/>
  <summary>6/26/2000--Introduced.
TABLE OF CONTENTS: Title I: Medicaid Prescription Drug Coverage for Low-Income Medicare Beneficiaries Title II: Improved Access of Americans to Health Insurance Coverage Subtitle A: Access of Medicare Beneficiaries to Medicare+Choice Plans Subtitle B: Access of the Self-Employed Subtitle C: Improve the Coverage of Needy Children under the State Children's Health Insurance Program (SCHIP) and the Medicaid Program Title III: Improved Access to Reasonably Priced Prescription Drugs Drug Availability and Health Care Access Improvement Act of 2000 - Title I: Medicaid Prescription Drug Coverage for Low-Income Medicare Beneficiaries - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require State Medicaid plans to cover prescribed drugs for qualified Medicare (SSA title XVIII) and other low-income Medicare beneficiaries. Provides full Federal funding for such Medicaid coverage.Title II: Improved Access of Americans to Health Insurance Coverage - Subtitle A: Access of Medicare Beneficiaries to Medicare+Choice Plans - Amends SSA title XVIII part C (Medicare+Choice) with respect to access to Medicare+Choice plans through an increase in the minimum Medicare+Choice capitation rate.Subtitle B: Access of the Self-Employed - Amends the Internal Revenue Code to provide for a tax deduction for the full amount of health insurance costs of self-employed individuals.Subtitle C: Improve the Coverage of Needy Children under the State Children's Health Insurance Program (SCHIP) and the Medicaid Program - Amends SSA titles XIX and XXI (State Children's Health Insurance Program) (SCHIP) to require the respective State Medicaid and SCHIP plans to provide for eligibility determinations, coordinated enrollment, and response to electronic communications received through the national toll-free system the Secretary shall establish.(Sec. 221) Amends SSA titles XIX and XXI to provide financial incentives to promote outreach and enrollment activities.Amends SSA title XIX to provide for additional entities qualified to determine Medicaid presumptive eligibility for low-income children.(Sec. 222) Amends SSA title XXI with respect to coordination of pediatric care within a family and reduction in the burden of administering cost-sharing provisions under SCHIP.(Sec. 223) Amends SSA title XIX and XXI to provide for automatic reassessment of eligibility for Medicaid and SCHIP benefits in the case of a child who loses eligibility for Medicaid or SCHIP benefits on the basis of changes in income, assets, or age.Amends SSA title XXI to authorize optional coverage of low-income, uninsured pregnant women under a State SCHIP plan.Amends SSA title XIX to give States the option to use an enhanced Federal medical assistance percentage for coverage of additional pregnant women under Medicaid.Amends SSA titles XIX and XXI to give States the option to cover qualified alien children under Medicaid and SCHIP.Amends the Immigration and Nationality Act to except child Medicaid or SCHIP assistance from the prohibition on seeking support from sponsors.Amends SSA title XXI to provide for: (1) elimination of the funding offset for exercise of the presumptive eligibility option under SCHIP; and (2) coordination of it with the Maternal and Child Health Services program under SSA title V.Title III: Improved Access to Reasonably Priced Prescription Drugs - Amends the Federal Food, Drug, and Cosmetic Act with regard to: (1) conditions for Food and Drug Administration (FDA) warning notices about imported drugs; and (2) consumer information in prescription drug advertising.(Sec. 303) Directs the Secretary to inform patients of the existence of programs operated by prescription drug manufacturers to provide such drugs to patients without charge.(Sec. 304) Expresses the sense of the Congress that: (1) the increased merger of drug manufacturers has resulted in a decrease in price competition in the prescription drug market and increased the potential for collusion in setting prices; and (2) the Antitrust Division of the Department of Justice and the Federal Trade Commission should give increased scrutiny to the anti-competitive effects of such mergers.</summary>
</bill>
